Amblyopia therapy

British Journal of Ophthalmology

Volumn 87, Issue 3, 2003, Pages 255-256

  Fleck, B W ^a  

^a PRINCESS ALEXANDRA EYE PAVILION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE;

AMBLYOPIA; ANISOMETROPIA; CLINICAL PRACTICE; EDITORIAL; EVIDENCE BASED MEDICINE; INTERMETHOD COMPARISON; PRIORITY JOURNAL; SPECTACLES; TREATMENT OUTCOME; TREATMENT PLANNING; VISUAL ACUITY;

ADOLESCENT; AGE FACTORS; AMBLYOPIA; ATROPINE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; EYEGLASSES; HUMANS; MYDRIATICS; PATIENT COMPLIANCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0037341653     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.3.255     Document Type: Editorial

References (28)

1. Snowdon SK, Stewart-Brown SL. Preschool vision screening. Health Technol Assess 1997;1:1-83.
2. Stewart-Brown SL, Snowdon SK. Evidence-based dilemmas in pre-school vision screening. Arch Dis Child 1998;78:406-7.
3. Mazow ML, Chuang A, Vital MC, et al. 1999 Costenbader Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 2000;4:1-9.
4. Mintz-Hittner HA, Fernandez KM. Successful amblyopia therapy initiated after age 7 years: compliance cures. Arch Ophthalmol 2000;118:1535-41.
5. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled data sets. Trans Am Ophthalmol Soc 1999;97:373-90.
6. Epelbaum M, Milleret C, Buisseret P, et al. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993;100:323-7.
7. Oliver M, Neumann R, Chaimovitch Y, et al. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986;102:340-5.
8. Cleary M. Efficacy of occlusion for strabismic amblyopia: can an optimal duratian be identified? Br J Ophthalmol 2000;84:572-8.
9. Watson PG, Sanac AS, Pickering MS. A comparison of various methods of treatment of amblyopia. A block study. Trans Ophthalmol Soc UK 1985;104 (Pt 3):319-28.
10. Moseley MJ, Neufeld M, McCarry B, et al. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt 2002;22:296-9.
11. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol 1997;81:54-7.
12. Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia, Ophthalmology 1997;104:2143-55.
13. Repka MX, Ray JM. The efficacy of optical and pharmacological penalization. Ophthalmology 1993;100:769-74.
14. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine v patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120:268-78.
15. Packwood EA, Cruz OA, Rychwalski PJ, et al. The psychosocial effects of amblyopia study. J AAPOS 1999;3:15-7.
16. Stewart CE, Fielder AR, Stephens DA, et al. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol 2002;86:915-9.
17. Holmes JM, Beck RW, Repka MX, et al. The amblyopia treatment study visual acuity testing protocol. Arch Ophthalmol 2001;119:1345-53.
18. Fielder AR, Auld R, Irwin M, et al. Compliance monitoring in amblyopia therapy. Lancet 1994;343:547.
19. Fells P. Richardson Cross lecture 1989 amblyopia - an historical perspective. Eye 1990;4 (Pt 6):775-86.
20. Leiba H, Shimshoni M, Oliver M, et al. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001;108:1552-5.
21. Simons K, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol 1999;83:582-7.
22. Clarke MWCHJ. Protocol for a single blind randomised multicentre controlled trial of treatment of unilateral visual acuity deficit detected at preschool vision screening. European Strabismological Society Meeting, September 2000; (abstract).
23. Moseley MJ, Fielder AR, Irwin M, et al. Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 1997;81:956-61.
24. Stewart CE, FAMMSDA. Dose-response relationship for occlusion therapy for the treatment of amblyopia: initial results from the MOTAS study. ARVO 2002. Abstract 2939.
25. Holmes JM, Beck RW, Repka MX. Amblyopia. Current clinical studies. Ophthalmol Clin North Am 2001;14:393-8.
26. Beck RW. The pediatric eye disease investigator group. J AAPOS 1998;2:255-6.
27. The Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol 2002;120:281-7.
28. Moke PS, Turpin AH, Beck RW, et al. Computerized method of visual acuity testing: adaptation of the amblyopia treatment study visual acuity testing protocol. Am J Ophthalmol 2001;132:903-9.